Race- and health-related quality of life among patients newly diagnosed with multiple myeloma.
Chris L. Pashos(Oldham Council), Zeba M. Khan(Bristol-Myers Squibb (Switzerland)), Brian G.M. Durie(Cedars-Sinai Medical Center), Robert M. Rifkin(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Sachdev Thomas(Illinois CancerCare), Rafat Abonour(Sylvester Comprehensive Cancer Center), Gale Harding(Policy Analysis (United States)), Kathleen Toomey(Somerville Hospital), Howard R. Terebelo(Michigan Cancer Research Consortium), Thomas K. Street(Bristol-Myers Squibb (Switzerland)), Arlene S. Swern, Kristen Sullivan(Tufts University), Jatin J. Shah(The University of Texas MD Anderson Cancer Center), Cristina Gasparetto(Duke Medical Center), Rafaël Fonseca(Mayo Clinic in Arizona), Jayesh Mehta(Northwestern University), Mohit Narang(Gettysburg College)
Cited by 1
Related Papers
Development and first validation of the COPD Assessment Test
|European Respiratory Journal|2009|3.2k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k